DRUG DELIVERY TECHNOLOGIES MARKET ANALYSIS
Drug Delivery Technologies Market - Competitive Landscape
Key players operating in the global drug delivery technologies market are focused on innovations related to drug delivery technologies, in order to improve patient compliance. For instance, in July 2018, Merck Pharmaceuticals and InnoCore Pharmaceuticals entered into a global collaboration agreement for InnoCore’s proprietary SynBiosys biodegradable polymer platform. The drug delivery technologies are used to develop sustained release solutions for biologicals in injectable formulations. The sustained release solutions play important role in drug formulation because it improve the patient adherence.
Some of the key players operating in the global drug delivery technologies market includes 3M, Bayer AG, Becton, Dickinson & Company, Johnson & Johnson, Pfizer, Inc., Novartis AG, Glaxosmithkline PLC, Vectura Group Plc., Roche Holding AG, Generex Biotechnology, Antares Pharma, Inc., Alkermes, Merck & Co., Inc, and Sanofi, Aradigm Corp.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
